Some 200 life sciences innovators, investors, and insiders crowded the offices of Mintz in downtown Boston last night as we announced the winners of the 8th annual M2D2 $200K Challenge. Out of a field of 19 Finalists, our judges selected 12 winners—a Challenge record.Continue reading
With support from the Deshpande Foundation, three finalist startups from an incubator in Chennai, India were able to pitch their life sciences innovations in Lowell on March 27. Not only did they compete, but they were also able to immerse themselves first-hand in the burgeoning biotech ecosystem that’s making Boston and environs the talk of the innovation economy.Continue reading
Dynocardia is 1 of 19 finalists chosen to pitch at the $200K Challenge Pitch-Off last Wednesday. Dynocardia’s ViTrack™ is the first-of-its-kind, standalone, cuff-less, wearable device for continuous non-invasive blood pressure monitoring.
Mohan Thanikachalam, CEO of Dynocardia, offers us an exclusive inside look behind the development of the ViTrackTM!Read more
V. Kadir Kadhiresan,
PhD – Vice President, Venture Investments at Johnson & Johnson
We’re thrilled to welcome Johnson & Johnson Innovation’s V. Kadir Kadhiresan as the keynote speaker for the $200K Challenge Award Celebration on 4/10 in Boston!Continue reading
On Wednesday night, nearly 250 attendees—life sciences innovators, investors, researchers, academics, and students—gatheredin UMass Lowell’s Maloney hall for the 2019 M2D2 $200K Challenge Pitch-Off.Continue reading
BuzzArk Simulations, chosen for their development of a VR simulation for natural orifice surgery procedures, is 1 of 20 MedTech startup finalists in the 8th annual M2D2 $200K Challenge.
Ragul Puhazhendi, Founder of Buzzark, offers us an exclusive inside look at the ups and downs behind the development of their simulation technology.
The UroMonitor, a device to simplify and improve the diagnosis and treatment of stress urinary incontinence, was chosen as 1 of 20 finalists in the 8th annual M2D2 $200K Challenge.
Margot Damaser of Cleveland Clinic leads a team in the development of the UroMonitor. In this article, Margot offers some insight into the background of the innovative device and what it’s taken her team to get it this far!
MediSim VR, one of 21 MedTech startup finalists in the 8th annual M2D2 $200K Challenge, was chosen to compete for their development of a Haptic enabled VR (virtual reality) surgery simulator.
Co-founder, Dr. Adith Chinnaswami, offers an exclusive inside look about this team’s innovation, background, and future plans.
Nuclease Probe Technologies, one of 21 MedTech startup finalists in the 8th annual M2D2 $200K Challenge, was chosen for their development of a novel diagnostic for accurate and early detection of bloodstream infections (BSI’s).
We spoke with Scientific Founder and CEO, James McNamara, who shared the story of their innovation with us.
Introducing CardioCorX, one of 21 MedTech startups chosen as finalists in the 8th annual M2D2 $200K Challenge. We spoke with CEO and President, Randy Werneth, who shared the story of their innovation.
CardioCorX was chosen for their development of a simple integrative medical approach for patients suffering from atrial fibrillation with or without heart failure.